Polymorphisms in microRNA-related genes are associated with survival of patients with T-cell lymphoma

Oncologist

Volumn 19, Issue 3, 2014, Pages 243-249

  Li, Xi ^a   Tian, Xiaobo ^a   Zhang, Bo ^a   Chen, Jieping ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

MicroRNAs; Polymorphisms; Survival; T cell lymphoma

Indexed keywords

MICRORNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOGENESIS; CANCER PROGNOSIS; CANCER STAGING; CHILD; CLINICAL FEATURE; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; T CELL LYMPHOMA; VERY ELDERLY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LYMPHOMA, T-CELL; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 84896467735     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2013-0370     Document Type: Article

References (34)

1. RizviMA, EvensAM, TallmanMSet al. T-cell non-Hodgkin lymphoma. Blood 2006; 107: 1255-1264.
2. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987-994.
3. Jaffe ES, Harris NL, Stein H et al. World Health Organization classification of tumours. Pathology and genetics of tumours of hematopoietic and lymphoid tissues. Lyon, France: IARC Press, 2001.
4. Han J, Lee Y, Yeom KH et al. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 2006; 125: 887-901.
5. Denli AM, Tops BB, Plasterk RH et al. Processing of primary microRNAs by the microprocessor complex. Nature 2004; 432: 231-235.
6. Lee YS, Nakahara K, Pham JWet al. Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell 2004; 117: 69-81.
7. Redfern AD, Colley SM, Beveridge DJ et al. RNAinduced silencing complex (RISC) proteins PACT, TRBP, and Dicer are SRA binding nuclear receptor coregulators. Proc Natl Acad Sci USA 2013; 110: 6536-6541.
8. Paik JH, Jang JY, Jeon YK et al. MicroRNA-146a downregulates NFKB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma. Clin Cancer Res 2011; 17: 4761-4771.
9. Jardin F, Figeac M. MicroRNAs in lymphoma, from diagnosis to targeted therapy. Curr Opin Oncol 2013; 25: 480-486.
10. Valencak J, Schmid K, Trautinger F et al. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas. J Dermatol Sci 2011; 64: 185-190.
11. Farre L, Bittencourt AL, Silva-Santos G et al. Fas-670 promoter polymorphism is associated to susceptibility, clinical presentation, and survival in adult T cell leukemia. J Leukoc Biol 2008; 83: 220-222.
12. Lee JJ, KimDH, LeeNYet al. Interleukin-10gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas. Br J Haematol 2007; 137: 329-336.
13. Iwai N, Naraba H. Polymorphisms in human pre-miRNAs. Biochem Biophys Res Commun 2005; 331: 1439-1444.
14. Li X, Tian X, ZhangBet al. Variationin Dicergene is associated with increased survival in T-cell lymphoma. PLoS One 2012; 7: e51640.
15. Carbone PP, Kaplan HS, Musshoff K et al. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971; 31: 1860-1861.
16. Ye Y, Wang KK, Gu J et al. Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prev Res (Phila) 2008; 1: 460-469.
17. Zhang HP, Singer BH. Recursive Partitioning and Applications. New York, NY: Springer, 2010.
18. Ramsdale E, van Besien K, Smith SM. Personalized treatment of lymphoma: Promise and reality. Semin Oncol 2011; 38: 225-235.
19. Maciejewski JP, Mufti GJ. Whole genome scanning as a cytogenetic tool in hematologic malignancies. Blood 2008; 112: 965-974.
20. Muljo SA, Ansel KM, Kanellopoulou C et al. Aberrant T cell differentiation in the absence of Dicer. J Exp Med 2005; 202: 261-269.
21. Lee Y, Ahn C, Han J et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003; 425: 415-419.
22. Lin RJ, Lin YC, Chen J et al. MicroRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma. Cancer Res 2010; 70: 7841-7850.
23. Lu J, Getz G, Miska EA et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838.
24. Macrae IJ, Zhou K, Li F et al. Structural basis for double-stranded RNA processing by Dicer. Science 2006; 311: 195-198.
25. Persson H, Kvist A, Rego N et al. Identification of new microRNAs in paired normal and tumor breast tissue suggestsadual role for theERBB2/Her2 gene. Cancer Res 2011; 71: 78-86.
26. Friedländer MR, Mackowiak SD, Li N et al. MiRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res 2012; 40: 37-52.
27. Guan X, Sturgis EM, Song X et al. Pre-microRNA variants predict HPV16-positive tumors and survival in patients with squamous cell carcinoma of the oropharynx. Cancer Lett 2013; 330: 233-240.
28. Hong MJ, Choi YY, Jang JA et al. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC. J Thorac Oncol 2013; 8: 703-710.
29. Tu HF, Liu CJ, Chang CL et al. The association between genetic polymorphism and the processing efficiency of miR-149 affects the prognosis of patients with head and neck squamous cell carcinoma. PLoS One 2012; 7: e51606.
30. AhnDH, Rah H, Choi YK et al. Association of the miR-146aC. G, miR-149T. C, miR-196a2T. C, and miR-499A. G polymorphisms with gastric cancer risk and survival in the Korean population. Mol Carcinog 2013; 52(suppl 1): E39-51.
31. Vasmatzis G, Johnson SH, Knudson RA et al. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. Blood 2012; 120: 2280-2289.
32. Callens C, Baleydier F, Lengline E et al. Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma. J Clin Oncol 2012; 30: 1966-1973.
33. Cronin-Fenton DP, Sharp L, Deady S et al. Treatment and survival for non-Hodgkin's lymphoma: Influence of histological subtype, age, and other factors in a population-based study (1999-2001). Eur J Cancer 2006; 42: 2786-2793.
34. Segal MR, Bloch DA. A comparison of estimated proportional hazards models and regression trees. Stat Med 1989; 8: 539-550.